三种结核疫苗候选株在山羊中的病理、微生物学与免疫学表现
在山羊经气管攻击结核分枝杆菌复合群后,评估热灭活牛分枝杆菌(HIMB)、噬菌体灭活山羊分枝杆菌(PIMC)和活体田鼠分枝杆菌(LMM)皮下接种的免疫、病理与微生物学效果。三种疫苗均与使用限定抗原的IFN-γ释放试验诊断兼容,其中HIMB和PIMC可诱导较强的抗MPB70/MPB83体液应答;接种组肺部及总病变严重程度评分显著降低,呼吸道淋巴结细菌负荷下降。
要点
- 三种候选疫苗均与限定抗原IFN-γ释放试验兼容
- HIMB与PIMC诱导体液免疫及吞噬活性增强,LMM未见
- 接种组肺部病变评分与淋巴结细菌负荷显著降低
核心结论
- 三种候选疫苗对山羊实验性M. caprae攻击均产生不同程度的保护效果,需进一步优化与研究。
研究设计与样本
- 在山羊模型中经气管攻击M. caprae,评价HIMB、PIMC和LMM皮下接种的免疫学、病理学与微生物学效果。
主要发现
- 疫苗使肺和总病变严重程度评分分别降低54%(HIMB)、44%(PIMC)和52%(LMM)。
- LMM降低总病变淋巴结体积,HIMB和LMM降低总矿化肺体积,HIMB降低肺病变矿化比例。
- 呼吸道淋巴结细菌负荷较未接种感染对照分别下降2.3(HIMB)、1.9(PIMC)和2.1(LMM)Log10。
- 呼吸道外病理和微生物学感染证据主要限于未接种感染组。
局限性
- 原文未系统列出局限性,仅指出需进一步优化与研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Test and cull-based animal tuberculosis eradication programs have not succeeded in eliminating TB in various regions and implementing those programs is not feasible in others. Vaccination represents an additional control tool under study. Here we evaluated the immunologic, pathologic, and microbiological effects of heat-inactivated Mycobacterium bovis (HIMB), phage-inactivated Mycobacterium caprae (PIMC) and live Mycobacterium microti (LMM) subcutaneous vaccination in goats challenged endotracheally with M. caprae. All three vaccines were compatible with interferon-γ release assay diagnosis using defined antigens but interfered slightly when this test was performed using standard tuberculins. HIMB and PIMC candidates induced a strong anti-MPB70/MPB83 humoral response, and a modest but significant increase in phagocytic activity and/or reactive oxygen species production by peripheral neutrophils and monocytes, features not observed with LMM vaccination. Vaccination significantly reduced the lung and total lesion severity score (by HIMB, PIMC and LMM; 54, 44 and 52%, respectively), the total lesioned lymph node volume (by LMM), the total mineralized lung volume (by HIMB and LMM) and the mineralized proportion of lung lesions (by HIMB). The bacterial burden of respiratory lymph nodes was reduced in vaccinates by 2.3 (HIMB), 1.9 (PIMC) and 2.1 (LMM) Log10 in comparison to the non-vaccinated infected control. Extra-respiratory pathological and microbiological evidence of infection was mainly restricted to goats from the non-vaccinated infected group. Vaccination with all three prototypes modulated the response of goats against M. caprae experimental challenge leading to varying levels of protective efficacy, highlighting the need for further optimization and research.
引用
- Fernández-Veiga L, Elguezabal N, Fuertes M, et al. Pathological, microbiological and immunological performance of three tuberculosis vaccine candidates in goats. Vaccine. 2026. PMID: 42800088. doi:10.1016/j.vaccine.2026.129196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。